380 related articles for article (PubMed ID: 15831900)
1. Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.
Min Y; Adachi Y; Yamamoto H; Imsumran A; Arimura Y; Endo T; Hinoda Y; Lee CT; Nadaf S; Carbone DP; Imai K
Gut; 2005 May; 54(5):591-600. PubMed ID: 15831900
[TBL] [Abstract][Full Text] [Related]
2. Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.
Min Y; Adachi Y; Yamamoto H; Ito H; Itoh F; Lee CT; Nadaf S; Carbone DP; Imai K
Cancer Res; 2003 Oct; 63(19):6432-41. PubMed ID: 14559833
[TBL] [Abstract][Full Text] [Related]
3. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines.
Adachi Y; Lee CT; Coffee K; Yamagata N; Ohm JE; Park KH; Dikov MM; Nadaf SR; Arteaga CL; Carbone DP
Gastroenterology; 2002 Oct; 123(4):1191-204. PubMed ID: 12360481
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
Li H; Adachi Y; Yamamoto H; Min Y; Ohashi H; Ii M; Arimura Y; Endo T; Lee CT; Carbone DP; Imai K; Shinomura Y
Cancer; 2011 Jul; 117(14):3135-47. PubMed ID: 21264842
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
6. Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy.
Adachi Y; Lee CT; Carbone DP
Novartis Found Symp; 2004; 262():177-89; discussion 190-2, 265-8. PubMed ID: 15562829
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
Lee CT; Park KH; Adachi Y; Seol JY; Yoo CG; Kim YW; Han SK; Shim YS; Coffee K; Dikov MM; Carbone DP
Cancer Gene Ther; 2003 Jan; 10(1):57-63. PubMed ID: 12489029
[TBL] [Abstract][Full Text] [Related]
8. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
9. Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers.
Wang Y; Adachi Y; Imsumran A; Yamamoto H; Piao W; Li H; Ii M; Arimura Y; Park MY; Kim D; Lee CT; Carbone DP; Imai K; Shinomura Y
J Gastroenterol; 2010 Feb; 45(2):159-70. PubMed ID: 19902140
[TBL] [Abstract][Full Text] [Related]
10. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
Reinmuth N; Liu W; Fan F; Jung YD; Ahmad SA; Stoeltzing O; Bucana CD; Radinsky R; Ellis LM
Clin Cancer Res; 2002 Oct; 8(10):3259-69. PubMed ID: 12374697
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status.
Ii M; Li H; Adachi Y; Yamamoto H; Ohashi H; Taniguchi H; Arimura Y; Carbone DP; Imai K; Shinomura Y
Clin Cancer Res; 2011 Aug; 17(15):5048-59. PubMed ID: 21642381
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma.
Imsumran A; Adachi Y; Yamamoto H; Li R; Wang Y; Min Y; Piao W; Nosho K; Arimura Y; Shinomura Y; Hosokawa M; Lee CT; Carbone DP; Imai K
Carcinogenesis; 2007 May; 28(5):947-56. PubMed ID: 17183068
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
Ohashi H; Adachi Y; Yamamoto H; Taniguchi H; Nosho K; Suzuki H; Arimura Y; Imai K; Carbone DP; Shinomura Y
Cancer Sci; 2012 Feb; 103(2):252-61. PubMed ID: 22044563
[TBL] [Abstract][Full Text] [Related]
14. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP
Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059
[TBL] [Abstract][Full Text] [Related]
16. The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.
Adachi Y; Ohashi H; Imsumran A; Yamamoto H; Matsunaga Y; Taniguchi H; Nosho K; Suzuki H; Sasaki Y; Arimura Y; Carbone DP; Imai K; Shinomura Y
Tumour Biol; 2014 Feb; 35(2):973-85. PubMed ID: 24026884
[TBL] [Abstract][Full Text] [Related]
17. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
[TBL] [Abstract][Full Text] [Related]
18. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G
Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898
[TBL] [Abstract][Full Text] [Related]
20. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
